TA-A001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTA-A001
Drug Alias NameTA-A001-topicalTA-A001TAA-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTALLC Corporation Inc
China Registration ClassN/A

Develop Information

Active CompaniesTALLC Corporation IncIACTA Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A